Sun Pharma Stock Hits Rough Patch Amid Profit Slump
Sun Pharmaceutical Industries experienced a sharp decline in stock value after reporting a 20% drop in consolidated net profit for Q1 2025. Despite a rise in total income and adjusted net profits, the company's shares fell nearly 6%, extending a previous decrease.
- Country:
- India
Shares of Sun Pharmaceutical Industries took a nosedive on Friday, dropping nearly 6% following the announcement of a 20% year-on-year decline in consolidated net profit for the first quarter ending June 30, 2025.
Continuing its downward trend from the previous day, Sun Pharma's stock plummeted 5.70% to Rs 1,608.30 on the BSE and by 5.78% to Rs 1,608 on the NSE.
The company, headquartered in Mumbai, reported a net profit of Rs 2,279 crore, a significant drop from Rs 2,836 crore in the same quarter the previous year, despite an increase in adjusted net profit and total income.
(With inputs from agencies.)
Advertisement
ALSO READ
Snoop Dogg's Leap Into Club Ownership: All Eyes on Swansea City
Bomb Threats Unsettle Delhi Schools, Sparks Swift Response
Indian nurse on death row in Yemen: Govt is taking good care of whatever is possible, observes SC.
Nvidia's CEO Jensen Huang: Bridging AI and Business in Beijing
New Central Auckland Police Station Opens, Boosting Safety and Crime Response
Google News